Rocket Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Basic and Diluted
Rocket Pharmaceuticals, Inc. (RCKT) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 55.38 million shares for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-01.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2021-03-01
- Rocket Pharmaceuticals, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-12-31 was 56.29M shares, a 9.88% increase year-over-year.
- Rocket Pharmaceuticals, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-09-30 was 55.19M shares, a 9.58% increase year-over-year.
- Rocket Pharmaceuticals, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-06-30 was 55.16M shares, a 11.96% increase year-over-year.
- Rocket Pharmaceuticals, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-03-31 was 54.88M shares, a 21.63% increase year-over-year.
- Rocket Pharmaceuticals, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 55.38M shares, a 13.00% increase from fiscal 2019.
- Rocket Pharmaceuticals, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 49.01M shares, a 24.46% increase from fiscal 2018.
- Rocket Pharmaceuticals, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 39.38M shares, a 479.46% increase from fiscal 2017.
- Rocket Pharmaceuticals, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2017 was 6.80M shares, a 0.56% decline from fiscal 2016.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2020-12-31 | 56.29M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | 55.74M shares derived: average of 2 quarters · filed 2021-03-01 | 55.55M shares derived: average of 3 quarters · filed 2021-03-01 | 55.38M shares 10-K · filed 2021-03-01 | ||||
| 2020-09-30 | 55.19M shares 10-Q · filed 2020-11-06 | 55.17M shares derived: average of 2 quarters · filed 2020-11-06 | 55.08M shares 10-Q · filed 2020-11-06 | 54.11M shares derived: average of 4 quarters · filed 2021-03-01 | ||||
| 2020-06-30 | 55.16M shares 10-Q · filed 2020-08-05 | 55.02M shares 10-Q · filed 2020-08-05 | 53.76M shares derived: average of 3 quarters · filed 2021-03-01 | 52.91M shares derived: average of 4 quarters · filed 2021-03-01 | ||||
| 2020-03-31 | 54.88M shares 10-Q · filed 2020-05-08 | 53.06M shares derived: average of 2 quarters · filed 2021-03-01 | 52.16M shares derived: average of 3 quarters · filed 2021-03-01 | 51.44M shares derived: average of 4 quarters · filed 2021-03-01 | ||||
| 2019-12-31 | 51.23M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | 50.80M shares derived: average of 2 quarters · filed 2021-03-01 | 50.29M shares derived: average of 3 quarters · filed 2021-03-01 | 49.01M shares 10-K · filed 2021-03-01 | ||||
| 2019-09-30 | 50.36M shares 10-Q · filed 2020-11-06 | 49.82M shares derived: average of 2 quarters · filed 2020-11-06 | 48.27M shares 10-Q · filed 2020-11-06 | 46.62M shares derived: average of 4 quarters · filed 2021-03-01 | ||||
| 2019-06-30 | 49.27M shares 10-Q · filed 2020-08-05 | 47.21M shares 10-Q · filed 2020-08-05 | 45.37M shares derived: average of 3 quarters · filed 2021-03-01 | 44.00M shares derived: average of 4 quarters · filed 2021-03-01 | ||||
| 2019-03-31 | 45.12M shares 10-Q · filed 2020-05-08 | 43.42M shares derived: average of 2 quarters · filed 2021-03-01 | 42.25M shares derived: average of 3 quarters · filed 2021-03-01 | 41.56M shares derived: average of 4 quarters · filed 2021-03-01 | ||||
| 2018-12-31 | 41.72M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | 40.81M shares derived: average of 2 quarters · filed 2021-03-01 | 40.37M shares derived: average of 3 quarters · filed 2021-03-01 | 39.38M shares 10-K · filed 2021-03-01 | ||||
| 2018-09-30 | 39.90M shares 10-Q · filed 2019-11-08 | 39.69M shares derived: average of 2 quarters · filed 2019-11-08 | 38.60M shares 10-Q · filed 2019-11-08 | 30.58M shares derived: average of 4 quarters · filed 2019-11-08 | ||||
| 2018-06-30 | 39.48M shares 10-Q · filed 2019-08-08 | 37.95M shares 10-Q · filed 2019-08-08 | 27.47M shares derived: average of 3 quarters · filed 2019-08-08 | 22.30M shares derived: average of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | 36.14M shares 10-Q · filed 2019-05-09 | 21.47M shares derived: average of 2 quarters · filed 2019-05-09 | 16.58M shares derived: average of 3 quarters · filed 2019-05-09 | 14.13M shares derived: average of 4 quarters · filed 2019-05-09 | ||||
| 2017-12-31 | 6.80M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-08 | 6.80M shares derived: average of 2 quarters · filed 2019-03-08 | 6.80M shares derived: average of 3 quarters · filed 2019-03-08 | 6.80M shares 10-K · filed 2019-03-08 | 6.77M shares 10-K · filed 2018-03-07 | |||
| 2017-09-30 | 6.80M shares 10-Q · filed 2018-11-09 | 27.04M shares 10-Q · filed 2017-11-08 | 6.80M shares derived: average of 2 quarters · filed 2018-11-09 | 6.80M shares 10-Q · filed 2018-11-09 | 27.01M shares 10-Q · filed 2017-11-08 | -8.06M shares derived: average of 4 quarters · filed 2019-03-08 | ||
| 2017-06-30 | 6.80M shares 10-Q · filed 2018-08-14 | 26.99M shares 10-Q · filed 2017-08-03 | 6.80M shares 10-Q · filed 2018-08-14 | 26.99M shares 10-Q · filed 2017-08-03 | -13.02M shares derived: average of 3 quarters · filed 2019-03-08 | -3.03M shares derived: average of 4 quarters · filed 2019-03-08 | ||
| 2017-03-31 | 6.80M shares 10-Q · filed 2018-05-11 | 26.99M shares 10-Q · filed 2017-05-10 | -22.92M shares derived: average of 2 quarters · filed 2019-03-08 | -6.31M shares derived: average of 3 quarters · filed 2019-03-08 | 1.93M shares derived: average of 4 quarters · filed 2019-03-08 | |||
| 2016-12-31 | -52.65M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-08 | -12.86M shares derived: average of 2 quarters · filed 2019-03-08 | 302.83K shares derived: average of 3 quarters · filed 2019-03-08 | 6.83M shares 10-K · filed 2019-03-08 | 26.74M shares 10-K · filed 2017-03-16 | |||
| 2016-09-30 | 26.93M shares 10-Q · filed 2017-11-08 | 26.78M shares derived: average of 2 quarters · filed 2017-11-08 | 26.66M shares 10-Q · filed 2017-11-08 | 26.62M shares derived: average of 4 quarters · filed 2017-11-08 | ||||
| 2016-06-30 | 26.62M shares 10-Q · filed 2017-08-03 | 26.52M shares 10-Q · filed 2017-08-03 | 26.52M shares derived: average of 3 quarters · filed 2017-08-03 | 25.53M shares derived: average of 4 quarters · filed 2017-08-03 | ||||
| 2016-03-31 | 26.42M shares 10-Q · filed 2017-05-10 | 26.46M shares derived: average of 2 quarters · filed 2017-05-10 | 25.17M shares derived: average of 3 quarters · filed 2017-05-10 | 22.96M shares derived: average of 4 quarters · filed 2017-05-10 | ||||
| 2015-12-31 | 26.50M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | 24.54M shares derived: average of 2 quarters · filed 2017-03-16 | 21.80M shares derived: average of 3 quarters · filed 2017-03-16 | 18.31M shares 10-K · filed 2017-03-16 | ||||
| 2015-09-30 | 22.57M shares 10-Q · filed 2016-11-09 | 19.45M shares derived: average of 2 quarters · filed 2016-11-09 | 15.58M shares 10-Q · filed 2016-11-09 | 11.90M shares derived: average of 4 quarters · filed 2016-11-09 | ||||
| 2015-06-30 | 16.33M shares 10-Q · filed 2016-08-10 | 12.03M shares 10-Q · filed 2016-08-10 | 8.34M shares derived: average of 3 quarters · filed 2016-08-10 | 6.51M shares derived: average of 4 quarters · filed 2016-08-10 | ||||
| 2015-03-31 | 7.68M shares 10-Q · filed 2016-05-11 | 4.35M shares derived: average of 2 quarters · filed 2016-05-11 | 3.24M shares derived: average of 3 quarters · filed 2016-05-11 | 2.68M shares derived: average of 4 quarters · filed 2016-05-11 | ||||
| 2014-12-31 | 1.02M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-23 | 1.02M shares derived: average of 2 quarters · filed 2016-03-23 | 1.02M shares derived: average of 3 quarters · filed 2016-03-23 | 1.02M shares 10-K · filed 2016-03-23 | ||||
| 2014-09-30 | 1.02M shares 10-Q · filed 2015-11-12 | 1.02M shares derived: average of 2 quarters · filed 2015-11-12 | 1.02M shares 10-Q · filed 2015-11-12 | |||||
| 2014-06-30 | 1.02M shares 10-Q · filed 2015-08-07 | 1.02M shares 10-Q · filed 2015-08-07 | ||||||
| 2014-03-31 | 1.02M shares 10-Q · filed 2015-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |